Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-20

FDA Approved: MACITENTAN — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved a generic macitentan from Sandoz Inc through an original application for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Macitentan (macitentan)

Snippet

ORIG AP for MACITENTAN (MACITENTAN)